{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:20Z","timestamp":1792519040113,"version":"4.5.0"},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40620-020-00772-7","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T11:04:15Z","timestamp":1591873455000},"page":"1069-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases)"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-965X","authenticated-orcid":false,"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"issue":"8","key":"772_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.autrev.2015.04.004","volume":"14","author":"A Bonanni","year":"2015","unstructured":"Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G et al (2015) Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference. Autoimmun rev 14(8):692\u2013702","journal-title":"Autoimmun rev"},{"issue":"11","key":"772_CR2","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1681\/ASN.2013090987","volume":"25","author":"M Bruschi","year":"2014","unstructured":"Bruschi M, Sinico RA, Moroni G, Pratesi F, Migliorini P, Galetti M et al (2014) Glomerular autoimmune multicomponents of human lupus nephritis in vivo: \u03b1-enolase and annexin AI. J Am Soc Nephrol 25(11):2483\u20132498","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"772_CR3","first-page":"3359","volume":"66","author":"AJ Kinloch","year":"2014","unstructured":"Kinloch AJ, Chang A, Ko K, Dunand CJH, Henderson S, Maienschein-Cline M et al (2014) Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis arthritis. Rheumatol 66(12):3359\u20133370","journal-title":"Rheumatol"},{"issue":"8","key":"772_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1681\/ASN.2014050493","volume":"26","author":"M Bruschi","year":"2015","unstructured":"Bruschi M, Galetti M, Sinico RA, Moroni G, Bonanni A, Radice A et al (2015) Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): planted antigens. J Am Soc Nephrol 26(8):1905\u20131924","journal-title":"J Am Soc Nephrol"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson A (2016) (2016) What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol 12:143\u2013153","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"772_CR6","doi-asserted-by":"publisher","first-page":"F287","DOI":"10.1152\/ajprenal.00533.2014","volume":"308","author":"J Fu","year":"2015","unstructured":"Fu J, Lee K, Chuang PY, Liu Z, He JC (2015) Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol 308(4):F287\u2013F297","journal-title":"Am J Physiol Renal Physiol"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41584-020-0401-9","volume":"12","author":"NI Maria","year":"2020","unstructured":"Maria NI, Davidson A (2020) Protecting the kidney in systemic lupus erythematosus:from diagnosis to therapy. Nat Rev Rheumatol 12:67. https:\/\/doi.org\/10.1038\/s41584-020-0401-9","journal-title":"Nat Rev Rheumatol"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK (2014) Type I interferon in the pathogenesis of lupus. J Immunol 192:5459\u20135468","journal-title":"J Immunol"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2009.117804","volume":"69","author":"NA Bassi","year":"2010","unstructured":"Bassi NA, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A et al (2010) IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 69:1704\u20131710","journal-title":"Ann Rheum Dis"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fimmu.2019.01461","volume":"10","author":"T de Oliveira","year":"2019","unstructured":"de Oliveira T, Souza DG, Teixeira MM, Amaral FA (2019) Tissue dependent role of PTX3 during ischemia-reperfusion injury. Front Immunol 10:1461","journal-title":"Front Immunol"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","volume":"49","author":"N Bassi","year":"2015","unstructured":"Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M et al (2015) PTX3, anti-PTX3, and anti-C1q autoantibodies in lupus glomerulonephritis. Clin Rev Allergy Immunol 49:217\u2013226","journal-title":"Clin Rev Allergy Immunol"},{"key":"772_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102443","author":"M Gatto","year":"2020","unstructured":"Gatto M, Radu C, Luisetto R, Ghirardello A, Bonsembiante F, Trez D et al (2020) Immunization with pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2020.102443","journal-title":"J Autoimmun"},{"issue":"2","key":"772_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241\u2013250","journal-title":"J Am Soc Nephrol"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40620-019-00698-9","volume":"1","author":"S Sciascia","year":"2020","unstructured":"Sciascia S, Radin M, Cecchi I, Fenoglio R, De Marchi A, Besso L, Baldovino S et al (2020) Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. J Nephrol 1:8. https:\/\/doi.org\/10.1007\/s40620-019-00698-9","journal-title":"J Nephrol"},{"issue":"5","key":"772_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s10067-019-04917-3","volume":"39","author":"X Ding","year":"2020","unstructured":"Ding X, Chen C, Zhang J, Lu G (2020) Antiphospholipid antibodies in patients with proliferative and membranous lupus nephritis. Clin Rheumatol 39(5):1531\u20131535","journal-title":"Clin Rheumatol"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I et al (2020) 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79:713\u2013723","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"772_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3899\/jrheum.110532","volume":"39","author":"D Wakasugi","year":"2012","unstructured":"Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y et al (2012) Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures. J Rheumatol 39(1):79\u201385","journal-title":"J Rheumatol"},{"issue":"2","key":"772_CR18","first-page":"332","volume":"34","author":"L Christopher-Stine","year":"2007","unstructured":"Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM (2007) Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 34(2):332\u2013335","journal-title":"J Rheumatol"},{"issue":"5","key":"772_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12(5):825\u2013835","journal-title":"Clin J Am Soc Nephrol"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaut.2016.06.006","volume":"74","author":"G Moroni","year":"2016","unstructured":"Moroni G, Depetri F, Ponticelli C (2016) Lupus nephritis: when and how often to biopsy and what does it mean? J Autoimmun 74:27\u201340","journal-title":"J Autoimmun"},{"issue":"8","key":"772_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0961203313492576","volume":"22","author":"G Moroni","year":"2013","unstructured":"Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C (2013) Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus 22(8):80\u201388","journal-title":"Lupus"},{"issue":"1","key":"772_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/lupus-2020-000389","volume":"18","author":"I Parodis","year":"2020","unstructured":"Parodis I, Tamirou F, Houssiau FA (2020) Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med 18(1):389. https:\/\/doi.org\/10.1136\/lupus-2020-000389","journal-title":"Lupus Sci Med"},{"issue":"19","key":"772_CR23","doi-asserted-by":"publisher","first-page":"30702","DOI":"10.1016\/j.semarthrit.2019.10.006","volume":"49","author":"T Falasinnu","year":"2019","unstructured":"Falasinnu T, O\u2019Shaughnessy M, Troxell ML, Charu V, Weisman H, Simard JF (2019) A review of non-immune mediated kidney disease in sytemic lupus erythematosus: a hypothetical model of putative risk factors. Semin Arthritis Rheum 49(19):30702\u201330704. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.10.006","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"772_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrneph.2014.38","volume":"10","author":"S Sciascia","year":"2014","unstructured":"Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D (2014) Renal involvement in antiphospholipid syndrome. Nat Rev Nephrol 10(5):279\u2013289","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"772_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40800-018-0073-4","volume":"18","author":"M Hajji","year":"2018","unstructured":"Hajji M, Jebali H, Mrad A, Blel Y, Brahmi N, Kheder R et al (2018) Nephrotoxicity of ciprofloxacin: five cases and a review of the literature. Drug Saf Case Rep 18(1):17","journal-title":"Drug Saf Case Rep"},{"issue":"3","key":"772_CR26","first-page":"434","volume":"32","author":"J Milburn","year":"2017","unstructured":"Milburn J, Jones R, Levy JB (2017) Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant 32(3):434\u2013439","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"772_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2215\/CJN.14331218","volume":"14","author":"M Bakhriansyah","year":"2019","unstructured":"Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH (2019) Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users. Clin J Am Soc Nephrol 14(9):1355\u20131362","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"772_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/art.40729","volume":"71","author":"A Jorge","year":"2019","unstructured":"Jorge A, Wallace ZS, Zhang Y, Lu N, Costenbader KH, Choi HK (2019) (2019) All-cause and cause-specific mortality trends of end-stage renal disease due to lupus nephritis from 1995 to 2014. Arthritis Rheumatol 71(3):403\u2013410","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"772_CR29","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","volume":"77","author":"G Moroni","year":"2018","unstructured":"Moroni G, Vercelloni PG, Quaglini S, Gatto M, Gianfreda D, Sacchi L et al (2018) Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis 77(9):1318\u20131325","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"772_CR30","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, Garrido R, Danieli MG et al (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46(8):2121\u20132131","journal-title":"Arthritis Rheum"},{"issue":"1","key":"772_CR31","first-page":"9","volume":"23","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Glassock RJ, Moroni G (2010) Induction and maintenance therapy in proliferative lupus nephritis. J Nephrol 23(1):9\u201316","journal-title":"J Nephrol"},{"issue":"4","key":"772_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1620\/tjem.227.281","volume":"227","author":"J Deng","year":"2012","unstructured":"Deng J, Huo D, Wu Q, Yang Z, Liao Y (2012) A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis. Tohoku J Exp Med 227(4):281\u2013288","journal-title":"Tohoku J Exp Med"},{"issue":"9","key":"772_CR33","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/rheumatology\/ket462","volume":"53","author":"G Moroni","year":"2014","unstructured":"Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del N et al (2014) Rituximab vs. mycophenolate and vs. cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study. Rheumatology (Oxford) 53(9):1570\u20131577","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR34","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/art.34359","volume":"64","author":"BH Rovin","year":"2012","unstructured":"Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J et al (2012) Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study. Arthritis Rheum 64:1215\u20131226","journal-title":"Arthritis Rheum"},{"issue":"1","key":"772_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ndt\/gfy267","volume":"34","author":"S Almaani","year":"2019","unstructured":"Almaani S, Rovin BH (2019) B-cell therapy in lupus nephritis: an overview. Nephrol Dial Transplant 34(1):22\u201329","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"772_CR36","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","volume":"365","author":"MA Dooley","year":"2011","unstructured":"Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D et al (2011) ALMS group mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365(20):1886\u20131895","journal-title":"N Engl J Med"},{"issue":"5","key":"772_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2215\/CJN.02271205","volume":"1","author":"G Moroni","year":"2006","unstructured":"Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S et al (2006) A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over 4 years. Clin J Am Soc Nephrol 1(5):925\u2013932","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"772_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14397595.2017.1352479","volume":"28","author":"M Sheikholeslami","year":"2018","unstructured":"Sheikholeslami M, Hajialilo M, Rasi Hashemi SS, Malek Mahdavi A, Gojazadeh M, Khabbazi A (2018) Low dose cyclosporine a in the treatment of resistant proliferative lupus nephritis. Mod Rheumatol 28(3):523\u2013529","journal-title":"Mod Rheumatol"},{"issue":"12","key":"772_CR39","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1681\/ASN.2017080830","volume":"28","author":"I Ayoub","year":"2017","unstructured":"Ayoub I, Rovin BH (2017) Calcineurin inhibitors in the treatment of lupus nephritis: a hare versus turtle story? J Am Soc Nephrol 28(12):3435\u20133437","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"772_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","volume":"95","author":"BH Rovin","year":"2019","unstructured":"Rovin BH, Solomons N, Pendergraft WF, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB (2019) A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int 95(1):219\u2013231","journal-title":"Kidney Int"},{"key":"772_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00706-3","author":"V Binda","year":"2020","unstructured":"Binda V, Trezzi B, Del Papa N, Beretta L, Frontini G, Porata G et al (2020 Jan 30) 2020) Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-020-00706-3","journal-title":"J Nephrol"},{"issue":"12","key":"772_CR42","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1681\/ASN.2017030263","volume":"28","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liu Z, Zhou M, Liu Z, Chen J, Xing C et al (2017) Multitarget therapy for maintenance treatment of lupus nephritis. J Am Soc Nephrol 28(12):3671\u20133678","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"772_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Moroni G (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf 16(3):411\u2013419","journal-title":"Expert Opin Drug Saf"},{"issue":"4 Suppl 78","key":"772_CR44","first-page":"S75","volume":"31","author":"G Moroni","year":"2013","unstructured":"Moroni G, Longhi S, Giglio E, Messa P, Ponticelli C (2013) What happens after complete withdrawal of therapy in patients with lupus nephritis. Clin Exp Rheumatol 31(4 Suppl 78):S75\u201381","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"772_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","volume":"97","author":"A Malvar","year":"2020","unstructured":"Malvar A, Alberton V, Lococo B, Ferrari M, Delgado P, Nagaraja HN, Rovin BH (2020) Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int 97(1):156\u2013162","journal-title":"Kidney Int"},{"issue":"2","key":"772_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nrneph.2015.174","volume":"12","author":"H Francois","year":"2016","unstructured":"Francois H, Mariette X (2016) Renal involvement in primary Sj\u00f6gren syndrome. Nat Rev Nephrol 12(2):82\u201393","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"772_CR47","first-page":"362","volume":"56","author":"M Jasiek","year":"2017","unstructured":"Jasiek M, Karras A, Le Guern V, Krastinova E, Mesbah R, Faguer S et al (2017) A multicentre study of 95 biopsy-proven cases of renal disease in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 56(3):362\u2013370","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"772_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12891-015-0858-x","volume":"5","author":"RD Evans","year":"2016","unstructured":"Evans RD, Laing CM, Ciurtin C, Walsh SB (2016) Tubulointerstitial nephritis in primary Sj\u00f6gren syndrome: clinical manifestations and response to treatment. BMC Musculoskelet Disord 5(17):2. https:\/\/doi.org\/10.1186\/s12891-015-0858-x","journal-title":"BMC Musculoskelet Disord"},{"key":"772_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1874312901408010103","volume":"8","author":"P Sandhya","year":"2014","unstructured":"Sandhya P, Danda D, Rajaratnam S, Thomas N (2014) Sj\u00f6gren\u2019s, renal tubular acidosis and osteomalacia\u2013An Asian Indian Series. Open Rheumatol J 8:103\u2013109","journal-title":"Open Rheumatol J"},{"issue":"4","key":"772_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.mnh.0000133975.32559.6b","volume":"13","author":"NS Krieger","year":"2004","unstructured":"Krieger NS, Frick KK, Bushinsky DA (2004) Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 13(4):423\u2013436","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"772_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.ackd.2018.05.003","volume":"25","author":"PG Vall\u00e9s","year":"2018","unstructured":"Vall\u00e9s PG, Batlle D (2018) Hypokalemic Distal renal tubular acidosis. Hypokalemic distal renal tubular acidosis. Adv Chronic Kidney Dis 25(4):303\u2013320","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"772_CR52","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1093\/ndt\/gfs493","volume":"27","author":"SK Haque","year":"2012","unstructured":"Haque SK, Ariceta G, Battle D (2012) Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant 27(12):4273\u20134287","journal-title":"Nephrol Dial Transplant"},{"key":"772_CR53","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","volume":"13","author":"J Rodriguez Soriano","year":"2002","unstructured":"Rodriguez Soriano J (2002) Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13:2160\u20132170","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"772_CR54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00296-006-0257-6","volume":"27","author":"YS Yang","year":"2007","unstructured":"Yang YS, Peng CH, Sia SK, Huang CN (2007) Acquired hypophosphatemia osteomalacia associated with Fanconi\u2019s syndrome in Sj\u00f6gren\u2019s syndrome. Rheumatol Int 27(6):593\u2013597","journal-title":"Rheumatol Int"},{"issue":"6","key":"772_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5414\/CNP65427","volume":"65","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Muto S, Nemoto J, Miyata Y, Ishiharajima S, Hironaka M et al (2006) Fanconi\u2019s syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sj\u00f6gren\u2019s syndrome with monoclonal gammopathy of undetermined significance. Clin Nephrol 65(6):427\u2013432","journal-title":"Clin Nephrol"},{"key":"772_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/03009740310003785","volume":"32","author":"A Bredberg","year":"2003","unstructured":"Bredberg A, Henriksson G, Larsson A et al (2003) A role of the macrophage in Sj\u00f6gen\u2019s syndrome? Scand J Rheumatol 32:255","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"772_CR57","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.00980209","volume":"4","author":"S Maripuri","year":"2009","unstructured":"Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC (2009) Renal involvement in primary Sj\u00f6gren\u2019s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 4(9):1423\u20131431","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"772_CR58","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","volume":"16","author":"N Bossini","year":"2001","unstructured":"Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M et al (2001) Clinical and morphological features of kidney involvement in primary Sj\u00f6gren\u2019s syndrome. Nephrol Dial Transplant 16(12):2328\u20132333","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"772_CR59","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/ndt\/gfv042","volume":"30","author":"D Kidder","year":"2015","unstructured":"Kidder D, Rutherford E, Kipgen D et al (2015) Kidney biopsy findings in primary Sj\u00f6gren syndrome. Nephrol Dial Transplant 30(8):1363\u20131369","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"772_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/1756-185X.13182","volume":"21","author":"HX Yang","year":"2018","unstructured":"Yang HX, Wang J, Wen YB, Fei YY, Jiang MD, Zhou MY (2018) Renal involvement in primary Sj\u00f6gren\u2019s syndrome: a retrospective study of 103 biopsy-proven cases from a single center in China. Int J Rheum Dis 21(1):223\u2013229","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"772_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nrneph.2015.174","volume":"12","author":"H Fran\u00e7ois","year":"2016","unstructured":"Fran\u00e7ois H, Mariette X (2016) (2016) Renal involvement in primary Sj\u00f6gren syndrome. Nat Rev Nephrol 12(2):82\u201393","journal-title":"Nat Rev Nephrol"},{"key":"772_CR62","first-page":"509","volume":"13","author":"S Dabadghao","year":"1995","unstructured":"Dabadghao S, Aggarwal A, Arora P, Pandey R, Misra R (1995) Glomerulonephritis leading to end stage renal disease in a patient with primary Sjogren syndrome. Clin Exp Rheumatol 13:509\u2013511","journal-title":"Clin Exp Rheumatol"},{"key":"772_CR63","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/0272-6386(95)90136-1","volume":"25","author":"MS Cortez","year":"1995","unstructured":"Cortez MS, Sturgill BC, Bolton WK (1995) Membranoproliferative glomerulonephritis with primary Sjogren\u2019s syndrome. Am J Kidney Dis 25:632\u2013636","journal-title":"Am J Kidney Dis"},{"key":"772_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/OARRR.S167783","volume":"11","author":"SG Pasoto","year":"2019","unstructured":"Pasoto SG, de Adriano V, Bonfa E (2019) Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol 11:33\u201345","journal-title":"Open Access Rheumatol"},{"key":"772_CR65","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3389\/fimmu.2019.01686","volume":"10","author":"J Imgenberg-Kreuz","year":"2019","unstructured":"Imgenberg-Kreuz J, Alml\u00f6f JC, Leonard D, Sj\u00f6wall C, Syv\u00e4nen AC, R\u00f6nnblom L et al (2019) Shared and unique patterns of dna methylation in systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. Front Immunol 10:1686","journal-title":"Front Immunol"},{"issue":"3","key":"772_CR66","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/j.ajkd.2014.11.032","volume":"66","author":"A Anand","year":"2015","unstructured":"Anand A, Krishna GG, Sibley RK, Kambham N (2015) Sj\u00f6gren syndrome and cryoglobulinemic glomerulonephritis. Am J Kidney Dis 66(3):532\u2013535","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"772_CR67","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.38100","volume":"65","author":"AV Goules","year":"2013","unstructured":"Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG (2013) Clinically significant renal involvement in primary Sj\u00f6gren\u2019s syndrome: clinical presentation and outcome. Arthr Rheum 65(11):2945\u20132953","journal-title":"Arthr Rheum"},{"issue":"8","key":"772_CR68","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/ndt\/gfv042","volume":"30","author":"D Kidder","year":"2015","unstructured":"Kidder D, Rutherford E, Kipgen D, Fleming S, Geddes C, Stewart GA (2015) Kidney biopsy findings in primary Sj\u00f6gren syndrome. Nephrol Dial Transplant 30(8):1363\u20131369","journal-title":"Nephrol Dial Transplant"},{"key":"772_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12891-015-0858-x","volume":"17","author":"RDR Evans","year":"2016","unstructured":"Evans RDR, Laing CM, Ciurtin C, Walsh SB (2016) Tubulointerstitial nephritis in primary Sj\u00f6gren syndrome: clinical manifestations and response to treatment. BMC Musculoskelet Disord 17:2","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"772_CR70","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00296-018-4118-x","volume":"38","author":"A Jain","year":"2018","unstructured":"Jain A, Srinivas BH, Emmanuel D, Jain VK, Parameshwaran FS, Negi VS (2018) Renal involvement in primary Sjogren\u2019s syndrome: a prospective cohort study. Rheumatol Int 38(12):2251\u20132262","journal-title":"Rheumatol Int"},{"issue":"1","key":"772_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, D\u00f6rner T et al (2020) EULAR-Sj\u00f6gren syndrome task force group. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3\u201318","journal-title":"Ann Rheum Dis"},{"key":"772_CR72","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373:393\u2013394","journal-title":"N Engl J Med"},{"key":"772_CR73","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/01.bor.0000141925.21941.d8","volume":"16","author":"L Christopher-Stine","year":"2004","unstructured":"Christopher-Stine L, Plotz PH (2004) Myositis: an update on pathogenesis. Curr Opin Rheumatol 16:700\u2013706","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"772_CR74","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1742-1241.2004.00248.x","volume":"59","author":"TH Yen","year":"2005","unstructured":"Yen TH, Lai PC, Chen CC, Hsueh S, Huang JY (2005) Renal involvement in patients with polymyositis and dermatomyositis. Int J Clin Pract 59(2):188\u2013193","journal-title":"Int J Clin Pract"},{"issue":"1","key":"772_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MD.0000000000000015","volume":"93","author":"G Couvrat-Desvergnes","year":"2014","unstructured":"Couvrat-Desvergnes G, Masseau A, Benveniste O, Bruel A, Hervier B, Mussini JM et al (2014) The spectrum of renal involvement in patients with inflammatory myopathies. Medicine (Baltimore) 93(1):33\u201341","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"772_CR76","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/ndt\/gfh950","volume":"20","author":"HW Kim","year":"2005","unstructured":"Kim HW, Choi JR, Jang SJ, Chang YS, Bang BK, Park CW (2005) Recurrent rhabdomyolysis and myoglobinuric acute renal failure in a patient with polymyositis. Nephrol Dial Transplant 20(10):2255\u20132258","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"772_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12016-015-8524-5","volume":"52","author":"D Cucchiari","year":"2017","unstructured":"Cucchiari D, Angelini C (2017) Renal involvement in Idiopathic inflammatory Myopathies. Clin Rev Allergy Immunol 52(1):99\u2013107","journal-title":"Clin Rev Allergy Immunol"},{"key":"772_CR78","first-page":"85","volume":"312","author":"V Thakur","year":"1996","unstructured":"Thakur V, DeSalvo J, McGrath H, Weed S, Garcia C (1996) Case report: Polymyositis-induced myoglobinuric acute renal failure. Am J Med Sci 312:85\u201387","journal-title":"Am J Med Sci"},{"key":"772_CR79","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/oxfordjournals.ndt.a027364","volume":"11","author":"AJ Lewington","year":"1996","unstructured":"Lewington AJ, D\u2019Souza R, Carr S, O\u2019Reilly K, Warwick GL (1996) Polymyositis: a cause of acute renal failure. Nephrol Dial Transplant 11:699\u2013701","journal-title":"Nephrol Dial Transplant"},{"key":"772_CR80","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ki.1996.48","volume":"49","author":"RA Zager","year":"1996","unstructured":"Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49:314\u2013326","journal-title":"Kidney Int"},{"issue":"1","key":"772_CR81","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/1319-2442.225181","volume":"29","author":"L Marisiddappa","year":"2018","unstructured":"Marisiddappa L, Desai AM, Kedlaya PG, Sathish R (2018) Recurrent Episodic myoglobinuric acute kidney injury as presenting manifestation of idiopathic polymyositis. Saudi J Kid Dis Transpl 29(1):210\u2013213","journal-title":"Saudi J Kid Dis Transpl"},{"issue":"1","key":"772_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra0801327","volume":"2","author":"X Bosch","year":"2009","unstructured":"Bosch X, Poch E, Grau JM (2009) Rhabdomyolysis and acute kidney injury. N Engl J Med 2(1):62\u201372","journal-title":"N Engl J Med"},{"issue":"3","key":"772_CR83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00296-018-4229-4","volume":"39","author":"MR Mantoo","year":"2019","unstructured":"Mantoo MR, Tripathy SK, Phulware RH, Bagri NK, Hari P, Barwad A (2019) Juvenile dermatomyositis with IgA nephropathy: case-based review. Rheumatol Int 39(3):577\u2013581","journal-title":"Rheumatol Int"},{"key":"772_CR84","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE (2015) Pathogenesis of systemic sclerosis. Front Immunol 6:272","journal-title":"Front Immunol"},{"issue":"3","key":"772_CR85","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1399-0039.2006.00657.x","volume":"68","author":"A Santaniello","year":"2006","unstructured":"Santaniello A, Salazar G, Lenna S, Antonioli R, Colombo G, Beretta L et al (2006) HLA-B35 upregulates the production of endothelin-1 in HLA-transfected cells: a possible pathogenetic role in pulmonary hypertension. Tissue Antigens 68(3):239\u2013244","journal-title":"Tissue Antigens"},{"issue":"9","key":"772_CR86","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.4049\/jimmunol.0903188","volume":"84","author":"S Lenna","year":"2010","unstructured":"Lenna S, Townsend DM, Tan FK, Kapanadze B, Markiewicz M, Trojanowska M et al (2010) HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells. J Immunol 84(9):4654\u20134661","journal-title":"J Immunol"},{"issue":"19","key":"772_CR87","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","volume":"22","author":"JE Martin","year":"2013","unstructured":"Martin JE, Assassi S, Diaz-Gallo LM, Broen JC, Simeon CP, Castellvi I et al (2013) A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet 22(19):4021\u20134029","journal-title":"Hum Mol Genet"},{"issue":"9","key":"772_CR88","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/qjmed\/hct111","volume":"106","author":"H Penn","year":"2013","unstructured":"Penn H, Quillinan N, Khan K, Chakravarty K, Ong VH, Burns A, Denton CP (2013) Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility. QJM 106(9):839\u2013848","journal-title":"QJM"},{"issue":"3","key":"772_CR89","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2249.2003.02320.x","volume":"134","author":"K Takagi","year":"2003","unstructured":"Takagi K, Kawaguchi Y, Hara M, Sugiura T, Harigai M, Kamatani N (2003) Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 134(3):538\u2013544","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 2","key":"772_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2362.2009.02117.x","volume":"39","author":"X Shiwen","year":"2009","unstructured":"Shiwen X, Leask A, Abraham DJ, Fonseca C (2009) Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. Eur J Clin Invest 39(Suppl 2):19\u201326","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"772_CR91","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","volume":"19","author":"AE Postlethwaite","year":"2007","unstructured":"Postlethwaite AE, Chiang TM (2007) Platelet contributions to the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 19(6):574\u2013599","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"772_CR92","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166(3):255\u2013263","journal-title":"J Pathol"},{"issue":"8","key":"772_CR93","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"H Penn","year":"2007","unstructured":"Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100(8):485\u2013494","journal-title":"QJM"},{"issue":"9","key":"772_CR94","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/anr.1780320911","volume":"32","author":"DJ Helfrich","year":"1989","unstructured":"Helfrich DJ, Banner B, Steen VD, Medsger TA (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32(9):1128\u20131134","journal-title":"Arthritis Rheum"},{"issue":"12","key":"772_CR95","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/rheumatology\/kez435","volume":"58","author":"H Yamashita","year":"2019","unstructured":"Yamashita H, Kamei R, Kaneko H (2019) Classifications of scleroderma renal crisis and reconsideration of its pathophysiology. Rheumatology (Oxford) 58(12):2099\u20132106","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR96","first-page":"843","volume-title":"Oxford Textbook of Clinical Nephrology","author":"CM Black","year":"2005","unstructured":"Black CM, Denton CP (2005) The patient with scleroderma-systemic sclerosis. In: Davison AM, Cameron JS, Grunfeld JP, Ponticelli C, Ritz E, Winearls CG, van Ypersele C (eds) Oxford Textbook of Clinical Nephrology, 3rd edn. Oxford University Press, Oxford, pp 843\u2013854","edition":"3"},{"key":"772_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1155\/2010\/543704","volume":"5","author":"I Batal","year":"2010","unstructured":"Batal I, Domsic RT, Medsger TA, Bastacky S (2010) Scleroderma crisis: a pathology perspective. Int J Rheumatol 5:4\u201337. https:\/\/doi.org\/10.1155\/2010\/543704","journal-title":"Int J Rheumatol"},{"issue":"6","key":"772_CR98","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s10157-017-1398-5","volume":"21","author":"K Ichikawa","year":"2017","unstructured":"Ichikawa K, Konta T, Sato H, Ueda Y, Yokoyama H (2017) The clinical and pathological characteristics of nephropathies in connective tissue diseases in the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 21(6):1024\u20131029","journal-title":"Clin Exp Nephrol"},{"key":"772_CR99","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","volume":"62","author":"XM Traub","year":"1983","unstructured":"Traub XM (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of 25 year experience with 68 cases. Medicine 62:335\u2013352","journal-title":"Medicine"},{"issue":"6","key":"772_CR100","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","volume":"44","author":"N Bose","year":"2015","unstructured":"Bose N, Chiesa-Vottero A, Chatterjee S (2015) Scleroderma renal crisis. Semin Arthritis Rheum 44(6):687\u2013694","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"772_CR101","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3899\/jrheum.151353","volume":"43","author":"M Turk","year":"2016","unstructured":"Turk M, Pope JE (2016) The frequency of scleroderma renal crisis over time: a metaanalysis. J Rheumatol 43(7):1350\u20131355","journal-title":"J Rheumatol"},{"key":"772_CR102","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","volume":"113","author":"JP Steen","year":"1990","unstructured":"Steen JP, Shapiro AP, Medsger TA (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352\u2013357","journal-title":"Ann Intern Med"},{"issue":"5\u20136","key":"772_CR103","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","volume":"33","author":"JG Walker","year":"2003","unstructured":"Walker JG, Ahern MJ, Smith MD, Coleman M, Pile K, Rischmueller M et al (2003) Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J 33(5\u20136):216\u2013220","journal-title":"Intern Med J"},{"key":"772_CR104","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","volume":"133","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133:600\u2013603","journal-title":"Ann Intern Med"},{"issue":"8","key":"772_CR105","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"H Penn","year":"2007","unstructured":"Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM et al (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100(8):485\u2013494","journal-title":"QJM"},{"issue":"12","key":"772_CR106","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","volume":"27","author":"F Cozzi","year":"2012","unstructured":"Cozzi F, Marson P, Cardarelli S, Favaro M, Tison T, Tonello M et al (2012) Prognosis of scleroderma renal crisis: a long-term observational study. Nephrol Dial Transplant 27(12):4398\u20134403","journal-title":"Nephrol Dial Transplant"},{"key":"772_CR107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40620-020-00746-9","volume":"24","author":"A Lavergne","year":"2020","unstructured":"Lavergne A, Pladys A, Couchoud C, Lassalle M, Vigneau C (2020) Systemic sclerosis and end-stage renal disease: study of patient characteristics, follow-up and outcomes in France. J Nephrol. 24:12. https:\/\/doi.org\/10.1007\/s40620-020-00746-9","journal-title":"J Nephrol."},{"issue":"4","key":"772_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0272-6386(99)70248-9","volume":"33","author":"NJ Caplin","year":"1999","unstructured":"Caplin NJ, Dikman S, Winston J, Spiera H, Uribarri J (1999) Recurrence of scleroderma in a renal allograft from an identical twin sister. Am J Kidney Dis 33(4):7","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"772_CR109","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5414\/CN109107","volume":"88","author":"N Saxena","year":"2017","unstructured":"Saxena N, Djamali A, Astor BC, Mohamed M, Mandelbrot D, Parajuli S (2017) A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma. Clin Nephrol 88(1):40\u201344","journal-title":"Clin Nephrol"},{"issue":"10103","key":"772_CR110","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699","journal-title":"Lancet"},{"issue":"7","key":"772_CR111","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/jch.13026","volume":"19","author":"JC Brokmann","year":"2017","unstructured":"Brokmann JC, Rossaint R, M\u00fcller M, Fitzner C, Villa L, Beckers SK, Bergrath S (2017) Blood pressure management and guideline adherence in hypertensive emergencies and urgencies: a comparison between telemedically supported and conventional out-of-hospital care. J Clin Hypertens (Greenwich) 19(7):704\u2013712","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"772_CR112","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ajh\/hpx048","volume":"30","author":"M Shah","year":"2017","unstructured":"Shah M, Patil S, Patel B, Arora S, Patel N, Garg L (2017) Trends in hospitalization for hypertensive emergency, and relationship of end-organ damage with in-hospital mortality. Am J Hypertens 30(7):700\u2013706","journal-title":"Am J Hypertens"},{"issue":"1380","key":"772_CR113","first-page":"39","volume":"126","author":"W van der Merwe","year":"2013","unstructured":"van der Merwe W, van der Merwe V (2013) Malignant hypertension: a preventable emergency. N Z Med 126(1380):39\u201345","journal-title":"N Z Med"},{"issue":"9","key":"772_CR114","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","volume":"17","author":"E Zanatta","year":"2018","unstructured":"Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, Doria A (2018) Therapy of scleroderma renal crisis: State of the art. Autoimmun Rev 17(9):882\u2013889","journal-title":"Autoimmun Rev"},{"issue":"2 Suppl 76","key":"772_CR115","first-page":"135","volume":"31","author":"G Montanelli","year":"2013","unstructured":"Montanelli G, Beretta L, Santaniello A, Scorza R (2013) Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series. Clin Exp Rheumatol 31(2 Suppl 76):135\u2013139","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"772_CR116","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/BOR.0000000000000604","volume":"31","author":"V Nagaraja","year":"2019","unstructured":"Nagaraja V (2019) Management of scleroderma renal crisis. Curr Opin Rheumatol 31(3):223\u2013230","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"772_CR117","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1081\/JDI-100107372","volume":"23","author":"EM Kfoury Baz","year":"2001","unstructured":"Kfoury Baz EM, Mahfouz RA, Masri AF, Jamaleddine GW (2001) Thrombotic thrombocytopenic purpura in a case of scleroderma renal crisis treated with twice-daily therapeutic plasma exchange. Ren Fail 23(5):737\u2013742","journal-title":"Ren Fail"},{"issue":"3","key":"772_CR118","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2169\/internalmedicine.1441-18","volume":"58","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A et al (2019) Scleroderma renal crisis complicated with thrombotic microangiopathy triggered by influenza b virus infection. Intern Med 58(3):441\u2013445","journal-title":"Intern Med"},{"issue":"30","key":"772_CR119","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MD.0000000000004459","volume":"95","author":"A Devresse","year":"2016","unstructured":"Devresse A, Aydin S, Quintrec M, Demoulin N, Stordeur P, Lambert C, Gastoldi S, Pirson Y, Jadoul M, Morelle J (2016) Complement activation and effect of eculizumab in scleroderma renal crisis. Medicine (Baltimore) 95(30):44\u201359","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"772_CR120","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/ckj\/sfw143","volume":"10","author":"M Allinovi","year":"2017","unstructured":"Allinovi M, Cirami CL, Caroti L, Antognoli G, Farsetti S, Amato MP, Minetti EE (2017) Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab. Clin Kidney J 10(5):625\u2013631","journal-title":"Clin Kidney J"},{"issue":"3","key":"772_CR121","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40620-016-0357-7","volume":"30","author":"A Asif","year":"2017","unstructured":"Asif A, Nayer A, Haas CS (2017) Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 30(3):347\u2013362","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00772-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:55:25Z","timestamp":1777564525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/4\/1069\/8325907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00772-7","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors do not have any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within 3\u00a0years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}